Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.

[1]  L. Domański,et al.  Is it possible to predict the early post‐transplant allograft function using 20‐HETE measurements? A preliminary report , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  S. Ledbetter,et al.  Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury. , 2009, Kidney international.

[3]  S. McCluskey,et al.  Acute Kidney Injury After Cardiac Surgery: Focus on Modifiable Risk Factors , 2009, Circulation.

[4]  R. Gross,et al.  Eicosanoid signalling pathways in the heart. , 2008, Cardiovascular research.

[5]  T. Gudermann,et al.  Gq‐coupled receptors as mechanosensors mediating myogenic vasoconstriction , 2008, EMBO Journal.

[6]  David W. Smith,et al.  Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. , 2008, American journal of physiology. Renal physiology.

[7]  M. Rothe,et al.  Cytochrome P450-dependent metabolism of eicosapentaenoic acid in the nematode Caenorhabditis elegans. , 2008, Archives of biochemistry and biophysics.

[8]  R. Montgomery,et al.  Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. , 2008, American journal of physiology. Renal physiology.

[9]  F. Park,et al.  20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells , 2008 .

[10]  K. Pritchard,et al.  20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. , 2008, American journal of physiology. Heart and circulatory physiology.

[11]  J. Falck,et al.  20-Hydroxyeicosatetraenoic Acid Stimulates Nuclear Factor-κB Activation and the Production of Inflammatory Cytokines in Human Endothelial Cells , 2008, Journal of Pharmacology and Experimental Therapeutics.

[12]  Bert Flemming,et al.  Viscosity of contrast media perturbs renal hemodynamics. , 2007, Journal of the American Society of Nephrology : JASN.

[13]  M. Schwartzman,et al.  Vascular Cytochrome P450 4A Expression and 20-Hydroxyeicosatetraenoic Acid Synthesis Contribute to Endothelial Dysfunction in Androgen-Induced Hypertension , 2007, Hypertension.

[14]  J. D. de Fijter,et al.  New horizons in prevention and treatment of ischaemic injury to kidney transplants. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  H. Hercule,et al.  Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat , 2006, Journal of hypertension.

[16]  N. Abraham,et al.  Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus , 2006, Circulation research.

[17]  J. Falck,et al.  Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. , 2005, Cardiovascular research.

[18]  S. Doggrell.  Taking the 20-HETE out of the cardiovascular system: the potential of 20-HETE synthesis inhibitors. , 2005, Current opinion in investigational drugs.

[19]  S. Okuyama,et al.  Beneficial Effects of a New 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, TS-011 [N-(3-Chloro-4-morpholin-4-yl) Phenyl-N′-hydroxyimido Formamide], on Hemorrhagic and Ischemic Stroke , 2005, Journal of Pharmacology and Experimental Therapeutics.

[20]  Rodrigo Gc,et al.  ATP-sensitive potassium channels. , 2005, Current pharmaceutical design.

[21]  N. Standen,et al.  ATP-sensitive potassium channels. , 2005, Current pharmaceutical design.

[22]  J. Falck,et al.  Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel. , 2004, Journal of molecular and cellular cardiology.

[23]  J. Bonventre,et al.  Ischemic acute renal failure: an inflammatory disease? , 2004, Kidney international.

[24]  J. Phillis,et al.  A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders , 2004, Brain Research Reviews.

[25]  R. Roman,et al.  Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats , 2003, Hypertension.

[26]  B. Molitoris,et al.  Microvascular endothelial injury and dysfunction during ischemic acute renal failure. , 2002, Kidney international.

[27]  J. Falck,et al.  Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. , 2002, Prostaglandins & other lipid mediators.

[28]  R. Roman,et al.  P-450 metabolites of arachidonic acid in the control of cardiovascular function. , 2002, Physiological reviews.

[29]  T. Ishii,et al.  Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. , 2001, Bioorganic & medicinal chemistry letters.

[30]  F. Luft,et al.  Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. , 2001, Kidney international.

[31]  T. Shimizu,et al.  An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Falck,et al.  20-HETE agonists and antagonists in the renal circulation. , 1999, American journal of physiology. Renal physiology.

[33]  J. Mcgiff,et al.  20-HETE and the kidney: resolution of old problems and new beginnings. , 1999, The American journal of physiology.

[34]  J. Falck,et al.  Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. , 1998, American journal of physiology. Renal physiology.

[35]  J. Falck,et al.  Cytochrome P450-derived renal HETEs: storage and release. , 1997, Kidney international.

[36]  R. Roman,et al.  Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. , 1997, American journal of hypertension.

[37]  J. Falck,et al.  Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. , 1996, The American journal of physiology.

[38]  R. Nemenoff,et al.  Subcellular characteristics of phospholipase A2 activity in the rat kidney. Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion. , 1991, The Journal of clinical investigation.

[39]  N. Abraham,et al.  Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. , 1989, Science.

[40]  A. S. Appel,et al.  Acute Renal Failure , 1960, Advances in Experimental Medicine and Biology.